IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.094
AS - Asia 4.476
EU - Europa 3.470
SA - Sud America 814
AF - Africa 111
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.011
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.933
SG - Singapore 1.888
CN - Cina 833
VN - Vietnam 731
BR - Brasile 672
RU - Federazione Russa 542
IT - Italia 537
FI - Finlandia 424
DE - Germania 355
GB - Regno Unito 311
SE - Svezia 310
UA - Ucraina 272
HK - Hong Kong 270
FR - Francia 214
LV - Lettonia 160
KR - Corea 145
IN - India 136
CA - Canada 101
ID - Indonesia 70
BG - Bulgaria 58
AR - Argentina 57
IQ - Iraq 54
BD - Bangladesh 53
ES - Italia 52
JP - Giappone 48
ZA - Sudafrica 46
NL - Olanda 44
PL - Polonia 42
TR - Turchia 42
AT - Austria 40
MX - Messico 40
JO - Giordania 37
AU - Australia 32
PK - Pakistan 30
LU - Lussemburgo 22
VE - Venezuela 20
PH - Filippine 17
MA - Marocco 16
CO - Colombia 15
UZ - Uzbekistan 14
EC - Ecuador 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
CL - Cile 11
CZ - Repubblica Ceca 11
IE - Irlanda 11
PY - Paraguay 11
NP - Nepal 10
SA - Arabia Saudita 10
BE - Belgio 9
KE - Kenya 9
TH - Thailandia 9
TN - Tunisia 9
LB - Libano 8
CH - Svizzera 7
EG - Egitto 7
IL - Israele 7
RO - Romania 7
UY - Uruguay 7
PE - Perù 6
TW - Taiwan 6
AZ - Azerbaigian 5
DZ - Algeria 5
ET - Etiopia 5
IR - Iran 5
NG - Nigeria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KH - Cambogia 4
OM - Oman 4
CR - Costa Rica 3
EU - Europa 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MT - Malta 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 22.992
Salva come PNG Salva come JPEG
Città #
Fairfield 1.720
Ashburn 1.410
Singapore 1.141
Chandler 956
Woodbridge 790
Seattle 706
San Jose 645
Houston 637
Jacksonville 610
Cambridge 587
Wilmington 569
Dallas 445
Santa Clara 358
San Mateo 334
Ann Arbor 330
Columbus 312
Helsinki 270
Moscow 246
Hong Kong 242
Los Angeles 241
Princeton 226
Beijing 198
The Dalles 193
Ho Chi Minh City 187
Hanoi 175
Trento 171
New York 160
Riga 160
Munich 156
Lauterbourg 142
Seoul 134
Council Bluffs 126
San Diego 120
London 98
Boardman 85
Dearborn 79
Lawrence 70
Orem 70
Chicago 69
Buffalo 64
São Paulo 64
Jakarta 60
Sofia 58
Como 56
San Francisco 56
Dong Ket 50
Da Nang 43
Nuremberg 42
Frankfurt am Main 41
Falls Church 40
Redondo Beach 39
Chennai 38
Tokyo 35
Bremen 34
Hefei 34
Montreal 33
Salt Lake City 32
Warsaw 32
Phoenix 31
Denver 30
Johannesburg 29
Toronto 28
Boston 27
Brooklyn 27
Norwalk 27
San Paolo di Civitate 27
Brasília 24
Milan 24
Haiphong 23
Tolentino 23
Guangzhou 22
Hesperange 22
Washington 22
Altamura 21
Belo Horizonte 21
Des Moines 21
Shanghai 21
Turku 21
Baghdad 20
Bend 20
Dublin 20
Rome 20
Atlanta 19
Elk Grove Village 19
Melbourne 19
Rio de Janeiro 19
Curitiba 17
Manchester 17
Mumbai 17
Barcelona 16
Changsha 16
Izmir 16
Kilburn 16
Vienna 16
Düsseldorf 15
Lappeenranta 15
Vancouver 14
Amsterdam 13
Andover 13
New Delhi 13
Totale 16.880
Salva come PNG Salva come JPEG
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 374
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 341
Inherited determinants of early recurrent somatic mutations in prostate cancer 331
A highly specific SpCas9 variant is identified by in vivo screening in yeast 309
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 290
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 268
Personalized in vitro and in vivo cancer models to guide precision medicine 247
ASEQ: Fast allele-specific studies from next-generation sequencing data 242
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 242
Genomic correlates of clinical outcome in advanced prostate cancer 236
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 234
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 232
Patient derived organoids to model rare prostate cancer phenotypes 231
EthSEQ: ethnicity annotation from whole exome sequencing data 219
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 218
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 214
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 208
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 207
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 206
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 201
Ancestry-specific predisposing germline variants in cancer 200
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 199
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 184
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 184
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 183
Clonal evolution of chemotherapy-resistant urothelial carcinoma 176
TPES: Tumor Purity Estimation from SNVs 176
A computational framework discovers new copy number variants with functional importance. 172
In-silico identification and functional validation of allele-dependent AR enhancers 168
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 168
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 167
A step toward functionally characterized prostate cancer molecular subtypes. 165
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 164
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 163
The long tail of oncogenic drivers in prostate cancer 163
The landscape of somatic copy-number alteration across human cancers. 161
The Molecular Taxonomy of Primary Prostate Cancer 161
Charting differentially methylated regions in cancer with Rocker-meth 161
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 160
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 159
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 159
Antibody-based detection of ERG rearrangement-positive prostate cancer. 158
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 156
Analytical protocol to identify local ancestry-associated molecular features in cancer 155
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. 153
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 151
Testing mutual exclusivity of ETS rearranged prostate cancer. 150
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations 149
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 147
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 146
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 145
Digital Pathology: Science Fiction? 145
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 144
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 144
EML4-ALK fusion lung cancer: a rare acquired event. 144
Plasma AR and abiraterone-resistant prostate cancer 144
Role of non-coding sequence variants in cancer 144
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 144
Variants at IRX4 as prostate cancer expression quantitative trait loci. 142
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 142
Tumor purity quantification by clonal DNA methylation signatures 141
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 139
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 138
Oncogene-mediated alterations in chromatin conformation 138
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment 138
Better screened than sorry!-an informed panel of inherited DNA repair gene variants for prostate cancer screening and prognostication 138
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 137
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 137
The virtual case: a new method to completely digitize cytological and histological slides. 137
The genomic complexity of primary human prostate cancer. 137
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 136
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 136
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 136
Punctuated evolution of prostate cancer genomes. 135
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 135
TMABoost: an integrated system for comprehensive management of tissue microarray data. 135
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 135
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 135
Large oncosomes mediate intercellular transfer of functional microRNA. 134
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 134
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 134
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. 133
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 133
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 133
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 133
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation 132
Tumor clone dynamics in lethal prostate cancer 132
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 131
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 131
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models 131
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 130
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 130
Mutation–selection balance and compensatory mechanisms in tumour evolution 130
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 129
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 129
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 129
Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients 128
Design and initial implementation of a regional tele-oncology project. 128
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 128
Recurrent gene fusions in prostate cancer 127
Totale 16.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 750
selected - selezionate 0
volume - volumi 438
Totale 96.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021553 0 0 0 0 0 0 0 0 0 0 282 271
2021/20222.157 249 327 14 92 36 81 83 390 137 212 181 355
2022/20232.024 267 235 13 328 210 316 30 145 252 34 122 72
2023/2024822 49 77 67 28 76 177 45 92 10 80 32 89
2024/20253.676 18 36 235 669 246 461 205 220 390 578 281 337
2025/20267.584 632 263 978 1.087 869 542 1.454 235 757 620 147 0
Totale 23.341